Pharmacokinetics of LEO 43204 Gel in Actinic Keratosis Administered Under Maximal Use Conditions

Clinical trial NCT02424305 · COMPLETED

Trial details

NCT number: NCT02424305
Sponsor: LEO Pharma
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Actinic Keratosis

Start date: 2015-05-01
Primary completion: 2015-07-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.